Trials / Recruiting
RecruitingNCT05340647
NorMIGS - a Study of Micro-invasive Glaucoma Surgery
NorMIGS - a Prospective Study of Micro-invasive Glaucoma Surgery
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Preserflo microshunt | Implantation of Preserflo microshunt (Santen) to lower intraocular pressure |
| PROCEDURE | Trabeculectomy | Trabeculectomy surgery to lower intraocular pressure |
| PROCEDURE | Other MIGS | Other MIGS than Preserflo microshunt (e.g., XEN gel stent, iStent inject) to lower intraocular pressure |
Timeline
- Start date
- 2022-04-22
- Primary completion
- 2023-12-01
- Completion
- 2028-06-01
- First posted
- 2022-04-22
- Last updated
- 2022-11-29
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT05340647. Inclusion in this directory is not an endorsement.